Microba Life Sciences Ltd (ASX:MAP) CEO Luke Reid speaks with Proactive at the ASX Small and Mid-Cap Conference September 2022. Microba is advancing healthcare through precision microbiome science. The company believes comprehensive and precise measurement of the human gut microbiome is required to drive innovation in medical care. Its therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases.
Microba Life Sciences with Proactive at ASX Small and Mid-Cap Conference
